Evidence map›Paper›PMID 11433278›Full record

ArticleNature biotechnology2001

A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter.

M Isalan, A Klug, Y Choo

Abstract read
In one paragraph

Article in Nature biotechnology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Application of Deep Sequencing in Phage Display.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  5. Article
  6. Article
  7. Genome Editing and Diabetic Cardiomyopathy.Advances in experimental medicine and biology · 2023
    Article
  8. Review
  9. CRISPR/Cas-Dependent and Nuclease-FreeHuman gene therapy · 2021
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Genome-Editing Technologies: Principles and Applications.Cold Spring Harbor perspectives in biology · 2016
    Review
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M IsalanMedical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK.
A Klug
Y Choo

Funding

Medical Research Council MC_U105184324Medical Research Council U.1051.04.011(78830)
6 · The paper itself

Abstract

DNA-binding domains with predetermined sequence specificity are engineered by selection of zinc finger modules using phage display, allowing the construction of customized transcription factors. Despite remarkable progress in this field, the available protein-engineering methods are deficient in many respects, thus hampering the applicability of the technique. Here we present a rapid and convenient method that can be used to design zinc finger proteins against a variety of DNA-binding sites. This is based on a pair of pre-made zinc finger phage-display libraries, which are used in parallel to select two DNA-binding domains each of which recognizes given 5 base pair sequences, and whose products are recombined to produce a single protein that recognizes a composite (9 base pair) site of predefined sequence. Engineering using this system can be completed in less than two weeks and yields proteins that bind sequence-specifically to DNA with Kd values in the nanomolar range. To illustrate the technique, we have selected seven different proteins to bind various regions of the human immunodeficiency virus 1 (HIV-1) promoter.

Indexed as

Genetic TechniquesPromoter Regions, GeneticZinc FingersAmino Acid SequenceBase SequenceBinding, CompetitiveDNADNA-Binding ProteinsHIV-1KineticsModels, MolecularMolecular Sequence DataPeptide LibraryPeptidesProtein BindingProtein Structure, TertiaryDNADNA-Binding ProteinsPeptide LibraryPeptides

Identifiers

PMID11433278
PMCPMC2677679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.